ArticleFrontiers in oncology2022

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case report.

Pascal Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.